Navigation Links
Seroquel to Treat Depression In Case Of Bipolar Disorder

AstraZeneca the Head of the Anglo-Swedish Company has come out with the results of the drug Seroquel stating that it be used in the treatment of // both maniac behaviour and mental depression in people suffering with bipolar disorders.

He has asked US to consider his drug as a sole treatment for maniac and depression symptoms related to bipolar disorder.

AstraZeneca, the drug czar has requested the number of drug regulators spread across the Atlantic to approve Seroquel.

Previously the drug was given permission to be used in the treatment of mania.

But now with his research and other works done at the base in Alderley Edge he has supplied new information based on clinical trail that it is very effective in treating patients suffering from mental depression.

Bipolar disorder is a characteristic mental imbalance in which the individual experience severe mood swings and also feels euphoric during episodes of mania and then immediately suffers from the lows characteristic of mental depression.

The incidence of this disease is very low and is about 3-4 % among the adults. It is the sixth leading cause of disability in the world.

Doctors say that the condition might be associated with genes and may be hereditary. It affects equal number of patients in both the sexes.

The acquiescence of the license for the new drug from the US Food and Drug Administration (FDA) would be an important milestone in the history of the drug.

The drug Seroquel alone spawned a profit of 1.16 billion pounds in 2004.


'"/>




Page: 1

Related medicine news :

1. Astra Zenecas Seroquel Gets FDA Approval For Schizophrenia
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. New FDA Approved Drug To Treat Migraine
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Angiotensin-II-receptor blockers - Treat kidney failure
8. Cipro Has Cheaper Cousins to Treat Anthrax
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. Cyclosporin A Treats Leukemia Complications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: